First-trimester maternal serum activin a in pre-eclampsia and fetal growth restriction

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 15, Issue 3, 2004, Pages 176-180

  Ong, C Y T ^a   Liao, A W ^a   Munim, S ^a   Spencer, K ^b   Nicolaides, K H ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b HAROLD WOOD HOSPITAL   (United Kingdom)

Author keywords

Activin A; Fetal growth restriction; First trimester; Pre eclampsia

Indexed keywords

ACTIVIN A;

ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MATERNAL SERUM; PREECLAMPSIA; PRIORITY JOURNAL;

ACTIVINS; CASE-CONTROL STUDIES; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INHIBIN-BETA SUBUNITS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RISK FACTORS;

EID: 2542466920     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.1080/14767050410001668275     Document Type: Article

References (26)

1. Massague J. The transforming growth factor beta family. Ann Rev Cell Biol 1990;6:597-641
2. Ying S-Y. Inhibins, activins and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev 1988;9:267-93
3. Qu J, Thomas K. Inhibin and activin production in human placenta. Endocr Rev 1995;16:485-507
4. Petraglia F, De Vita D, Gallinelli A, et al. Abnormal concentration of maternal serum activin-A in gestational diseases. J Clin Endocrinol Metab 1995;80:558-61
5. Petraglia F, Aguzzoli L, Gallinelli A, et al. Hypertension in pregnancy: changes in activin A maternal serum concentration. Placenta 1995;16:447-54
6. Muttukrishna S, Knight PG, Groome NP, et al. Activin A and inhibin A as possible endocrine markers for pre-eclampsia. Lancet 1997;349:1285-8
7. Silver HM, Lambert-Messerlian GM, Star JA, et al. Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies. Am J Obstet Gynecol 1999;180:1131-7
8. Laivuori H, Kaaja R, Turpeinen U, et al. Serum activin A and inhibin A elevated in pre-eclampsia: no relation to insulin sensitivity. Br J Obstet Gynaecol 1999;106:1298-303
9. D'Antona D, Reis FM, Benedetto C, et al. Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders. J Endocrinol 2000;165:157-62
10. Multuhrishna S, North RA, Morris J, et al. Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Hum Reprod 2000;15:1640-5
11. Florio P, Reis FM, Rezzari I, et al. The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2003;21:165-9
12. Keelan JA, Taylor R, Schellenberg JC, et al. Serum activin A, inhibin A and follistatin concentrations in pre-eclampsia or small for gestational age pregnancies. Obstet Gynecol 2002;99:267-74
13. Davidson EJ, Riley SC, Roberts SA, et al. Maternal serum activin, inhibin, human chorionic gonadotrophin and α-fetoprotein as second trimester predictors of pre-eclampsia. Br J Obstet Gynaecol 2003;110:46-52
14. Wallace EM, Schneider-Kolsky ME, Edwards A, et al. Maternal serum activin A levels in association with intrauterine fetal growth restriction. Br J Obstet Gynaecol 2003;110:306-10
15. Keelan JA, Taylor R, Schellenberg JC, et al. Serum activin A, inhibin A, and follistatin concentrations in preeclampsia or small for gestational age pregnancies. Obstet Gynecol 2002;99:267-74
16. Genbacev O, Joslin R, Damsky CH, et al. Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J Clin Invest 1996;97:540-50
17. Pijnenborg R, Anthony J, Davey DA, et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991;98:648-55
18. Khong TY, De Wolf F, Robertson WB, et al. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986;93:1049-59
19. Papageorghiou AT, Yu CKH, Bindra R, et al. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 2001;18:441-9
20. Martin AM, Bindra R, Curcio P, et al. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 2001;18:583-6
21. Spencer K, Souter V, Tul N, et al. A screening programme for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β human chorionic gonadotropin and pregnancy associated plasma protein A. Ultrasound Obstet Gynecol 1999;13:231-7
22. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988;158:892-8
23. Yudkin PL, Aboualfa M, Eyre JA, et al. New birthweight and head circumference centiles for gestational ages 24 to 42 weeks. Early Hum Dev 1987;15:45-52
24. Engelese MA, Neele JM, van Achterberg TA, et al. Human activin-A is expressed in the atherosclerotic lesion and promotes the contractile phenotype of smooth muscle cells. Circ Res 1999;85:931-9
25. Brown MR, Vaughan J, Jimenez LL, et al. Transforming growth factor-beta: role in mediating serum-induced endothelin production by vascular endothelial cells. Endocrinology 1991;129:2355-60
26. Nusing RM., Barsig J. Induction of prostanoid, nitric oxide and cytokine formation in rat bone marrow derived macrophages by activin A. Br J Pharmacol 1999;127:919-26